www.trustedrxapproved.net

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Zidovudine - Combivir, Retrovir

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Combivir

Generic Combivir

Lamivudine - Zidovudine 150mg + 300mg

Generic Combivir is in a group of medicines called reverse transcriptase inhibitors. It is used for treating HIV infection in combination with other medicines.
More info »

$1.75 Buy now!
Retrovir

Generic Retrovir

Zidovudine 100/300mg

Generic Retrovir is used for treating HIV infection when used along with other medicines. It is also used with other medicines to help prevent women from passing the HIV virus to the fetus during pregnancy.
More info »

$1.42 Buy now!
Language/Idioma/Sprache:
Social bookmarks:
Testimonials

Good Morning:
The generic V is as expected, makes a good thing better, and the price is such that it is used all the time. Eliminates performance anxiety !
Thank you for your help. - Sincerely, Steve

Our billing is certified by:

Secure shopping certificates


Special Offer!

News

  • Aurobindo Pharma gets US FDA approval for lamivudine & zidovudine tabs - pharmabiz.com

    Moneycontrol.

  • Lupin Launches Generic Combivir Tablets - RTT News

    Moneycontrol.

  • Lupin, Aurobindo get USFDA nod for HIV drug - Economic Times

    Lupin, Aurobindo get USFDA nod for HIV drugEconomic TimesLupin Pharmaceuticals Inc, a subsidiary of Lupin Ltd, has received final approval from US Food and Drug Administration (USFDA) for its generic Lamivudine and Zidovudine combination tablet in strength of 150mg/300 mg, Lupin said in a statement.

  • HIV positive patients face bleak future - NewsDay

    HIV positive patients face bleak futureNewsDayZimbabwe started phasing out the combination anti-retroviral treatment (ARV) Stavudine, Lamivudine and Nevirapine as its first-line option for the national programme, replacing it with the less toxic Tenofovir and Zidovudine-based regimens.

  • LANDMARK HIV DRUG'S PATENT EXPIRES TODAY - U-T San Diego

    LANDMARK HIV DRUG'S PATENT EXPIRES TODAYU-T San DiegoThe FDA approved Combivir (lamivudine/zidovudine) in 1997, greatly changing the treatment of HIV/AIDS.

bookmark Bookmark this site
Subscribe to the News
Trusted. Rx approved.